首页> 外国专利> METHODS FOR IMPROVING THYMIC RECOVERY AND PREVENTING AND TREATING GRAFT VERSUS HOST DISEASE USING CCR2 AND CCR5 ANTAGONISTS

METHODS FOR IMPROVING THYMIC RECOVERY AND PREVENTING AND TREATING GRAFT VERSUS HOST DISEASE USING CCR2 AND CCR5 ANTAGONISTS

机译:使用CCR2和CCR5拮抗剂改善胸腺的恢复,预防和治疗移植物抗宿主病的方法

摘要

The presently disclosed subject matter provides that blockade of CCR2 alone or CCR2 and CCR5 together improves thymic recovery and thymic immune function and treats or prevents graft versus host disease ("GVHD") and organ transplant rejection. Accordingly, the disclosed subject matter provides methods for increasing thymic recovery or thymic function in a subject, e.g., a human subject, by administering to the subject an effective amount of a CCR2 antagonist, a CCR5 antagonist and a CCR2 antagonist, or a dual CCR2/CCR5 antagonist. The presently disclosed subject matter also provides methods for treating, inhibiting, or preventing GVHD or organ transplant rejection in a subject, e.g., a human subject, by administering to the subject an effective amount of a CCR2 antagonist alone, a CCR5 antagonist and a CCR2 antagonist, or a dual CCR2/CCR5 antagonist.
机译:当前公开的主题提供了单独阻断CCR2或阻断CCR2和CCR5一起改善了胸腺的恢复和胸腺的免疫功能,并治疗或预防了移植物抗宿主病(“ GVHD”)和器官移植排斥。因此,所公开的主题提供了通过向受试者施用有效量的CCR2拮抗剂,CCR5拮抗剂和CCR2拮抗剂或双重CCR2来增加受试者例如人受试者的胸腺恢复或胸腺功能的方法。 / CCR5拮抗剂。本公开的主题还提供了通过向受试者施用有效量的单独的CCR2拮抗剂,CCR5拮抗剂和CCR2来治疗,抑制或预防受试者例如人受试者中的GVHD或器官移植排斥的方法。拮抗剂,或双重CCR2 / CCR5拮抗剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号